EUDA Health Holdings Limited (NASDAQ:EUDA) Shares Shorted: Short Interest Down 38.0% in September

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a significant decrease in short interest in September. As of September 15th, there was short interest totaling 1,589 shares, a decrease of 38.0% from the August 31st total of 2,561 shares. Based on an average trading volume of 41,368 shares, the short-interest ratio is currently 0.0 days. Currently, 0.1% of the shares of the company are short sold.

EUDA Health Trading Up 4.8%

Shares of NASDAQ:EUDA traded up $0.68 during trading on Thursday, reaching $14.98. The company had a trading volume of 5,889 shares, compared to its average volume of 51,048. EUDA Health has a fifty-two week low of $5.26 and a fifty-two week high of $86.00. The stock’s fifty day moving average price is $15.56 and its 200 day moving average price is $13.69.

EUDA Health (NASDAQ:EUDA) last announced its quarterly earnings data on Tuesday, September 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.57). The business had revenue of $1.73 million for the quarter, compared to the consensus estimate of $9.61 million.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of EUDA Health in a research note on Wednesday, August 5th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $55.00.

EUDA Health Company Profile

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market.